P-103 Refinement of Population Pharmacokinetic Model of Certolizumab Pegol in Crohnʼs Disease Patients to Account for Time Varying Nature of Covariates | Zendy

AI Assistant Blog Pricing

P-103 Refinement of Population Pharmacokinetic Model of Certolizumab Pegol in Crohnʼs Disease Patients to Account for Time Varying Nature of Covariates

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.